Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason Scores

Eur Urol. 2019 Jun;75(6):1038-1040. doi: 10.1016/j.eururo.2019.01.010. Epub 2019 Jan 22.

Authors

Brandon A Mahal¹, Mohammed Alshalalfa², Daniel E Spratt³, Elai Davicioni⁴, Shuang G Zhao³, Felix Y Feng², Timothy R Rebbeck⁵, Paul L Nguyen⁶, Franklin W Huang²

Affiliations

¹ Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA. Electronic address: brandon_mahal@dfci.harvard.edu.
² University of California at San Francisco, San Francisco, CA, USA.
³ University of Michigan, Ann Arbor, MI, USA.
⁴ GenomeDx Inc., San Diego, CA, USA.
⁵ Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA; Harvard TH Chan School of Public Health, Boston, MA, USA.
⁶ Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.

PMID: 30683576
DOI: 10.1016/j.eururo.2019.01.010

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adenocarcinoma / genetics*
Adenocarcinoma / pathology
Adenocarcinoma / secondary
Adenocarcinoma / surgery
Black or African American*
Genomics*
Health Status Disparities*
Healthcare Disparities / ethnology
Humans
Male
Neoplasm Grading
Neoplasm Metastasis
Prostatectomy
Prostatic Neoplasms / genetics*
Prostatic Neoplasms / pathology
Prostatic Neoplasms / surgery
Risk Assessment
Transcriptome*
White People*

Grants and funding

P20 CA233255/CA/NCI NIH HHS/United States